Prognostic value of six-minute walk test to predict postoperative cardiopulmonary complications in non-small cell lung cancer patients
Chest Jan 29, 2020
Lee H, Kim HK, Kang D, et al. - Whether a six-minute walk test (6MWT) has a role in predicting postoperative cardiopulmonary complications among non-small cell lung cancer (NSCLC) patients who had a lobectomy and showed moderately reduced lung function, was investigated in this study utilizing data from a prospective cohort investigation named Coordinate Approach To Cancer patient’s Health for Lung Cancer (CATCH – LUNG). Cases treated with lobectomy for NSCLC and with ECOG status 0 or 1 were examined. Two groups of patients were defined based on predicted postoperative pulmonary function (low-risk group or moderate-risk group). Further categorization of each group was done into short-distance (< 400m) or long-distance (≥ 400m) groups by a six-minute walk distance. The incidence of postoperative cardiopulmonary complications developing within the first 30 days after surgery was the main endpoint. While a greater risk of postoperative cardiopulmonary complications was observed in NSCLC patients with moderate-risk/short-distance, findings revealed the feasibility of undergoing lobectomy among NSCLC patients with moderate-risk/long-distance vs those with low-risk/long-distance. In the detection of optimal candidates for lung resection surgery of NSCLC, additional information could be gained via 6MWT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries